This clinical study main goal is to investigate the effectiveness of nano hydroxy apatite crystal varnish and potassium nitrate gel as a non invasive approach in managing MIH-affected teeth.
This randomized clinical trial study aims to investigate the effectiveness of nano-hydroxy apatite crystal varnish, and potassium nitrate gel compared to fluoride varnish, in reducing dentin hypersensitivity, improving a child's oral hygiene, and gingival health, oral health-related quality of life, preventing post-eruptive enamel breakdown, and dental caries, along with economic evaluation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
Intervention (1)
Intervention (2)
Control
Dentin Hypersensitivity
Measured by: Face scale: scores from 0-4. the higher the score the worse the sensitivity.
Time frame: Baseline, 15 miutes pot-op, 2 weeks post-op, and 4 weeks post op.
Dentin Hypersensitivity
Measured by: Schiff Cold Air Blasting Sensitivity Scale: scores from 0-3. The higher the score the worse the sensitivity.
Time frame: Baseline, 15 miutes pot-op, 2 weeks post-op, and 4 weeks post op.
Post-eruptive enamel breakdown
Measured by Wurzburg Molar Incisor Hypomineralization - Treatment Need Index (MIH-TNI): ordinal scores: 1,2,3, 4a, 4b, 4c.
Time frame: : baseline, 3-, 6-, 9-, and 12- month post-op.
Caries incidence
Measured by International Caries Detection and Assessment System (ICDAS II) criteria: scores from 0-6. The higher the score the worse the caries.
Time frame: baseline, 3-, 6-, 9-, and 12- month post-op.
Oral hygiene
Measured by Plaque Control Record: Percentage.
Time frame: baseline, 2-, and 4- week post-op.
Oral health-related quality of life
Measured by: Short form Parental-Caregiver Perceptions Questionnaire (P-CPQ): from 0 -32. The higher the score the worse the Oral Health Related Quality of Life.
Time frame: baseline, 6-, and 12- month post-op.
Cost Effectiveness Ratio (CER) and Incremental Cost Effectiveness Ratio (ICER
Measured by: Equation : CER = C / E, where C is the average direct medical cost calculated for the group, and E is the health effectiveness measure for the same group (change in hypersensitivity score). ICER = (CI - CC) / (EI - EC), where CI is the average direct medical cost of the intervention group CC is the average direct medical cost in the control group, EI is the health effectiveness measure (change in hypersensitivity score) in the intervention group, and EC is the health effectiveness measure in the control group
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 12-month- post-op.